On the other hand, the 12S rRNA 1494C > T mutation has been associated with both aminoglycoside-induced and nonsyndromic hearing loss only in some Chinese and Spanish families [11-13]..
Trang 1R E S E A R C H Open Access
Frequency and spectrum of mitochondrial 12S rRNA variants in 440 Han Chinese hearing
impaired pediatric subjects from two otology
clinics
Zhisen Shen1, Jing Zheng2, Bobei Chen3, Guanghua Peng3,4, Ting Zhang2, Shasha Gong2, Yi Zhu2,5,
Chuqin Zhang3, Ronghua Li6, Li Yang6, Jianjin Zhou1, Ting Cai1, Lihua Jin1, Jianxin Lu2, Min-Xin Guan2,6,7*
Abstract
Background: Aminoglycoside ototoxicity is one of the common health problems Mitochondrial 12S rRNA
mutations are one of the important causes of aminoglycoside ototoxicity However, the incidences of 12S rRNA mutations associated with aminoglycoside ototoxicity are less known
Methods: A total of 440 Chinese pediatric hearing-impaired subjects were recruited from two otology clinics in the Ningbo and Wenzhou cities of Zhejiang Province, China These subjects underwent clinical, genetic evaluation and molecular analysis of mitochondrial 12S rRNA Resultant mtDNA variants were evaluated by structural and
phylogenetic analysis
Results: The study samples consisted of 227 males and 213 females The age of all participants ranged from
1 years old to 18 years, with the median age of 9 years Ninety-eight subjects (58 males and 40 females) had a history of exposure to aminoglycosides, accounting for 22.3% cases of hearing loss in this cohort Molecular
analysis of 12S rRNA gene identified 41 (39 known and 2 novel) variants The incidences of the known deafness-associated 1555A > G, 1494C > T and 1095T > C mutations were 7.5%, 0.45% and 0.91% in this entire hearing-impaired subjects, respectively, and 21.4%, 2% and 2% among 98 subjects with aminoglycoside ototoxicity,
respectively The structural and phylogenetic evaluations showed that a novel 747A > G variant and known 839A >
G, 1027A > G, 1310C > T and 1413T > C variants conferred increased sensitivity to aminoglycosides or
nonsyndromic deafness as they were absent in 449 Chinese controls and localized at highly conserved nucleotides
of this rRNA However, other variants were polymorphisms Of 44 subjects carrying one of definite or putative deafness-related 12S rRNA variants, only one subject carrying the 1413T > C variant harbored the 235DelC/
299DelAT mutations in the GJB2 gene, while none of mutations in GJB2 gene was detected in other 43 subjects Conclusions: Mutations in mitochondrial 12S rRNA accounted for ~30% cases of aminoglycoside-induced deafness
in this cohort Our data strongly support the idea that the mitochondrial 12S rRNA is the hot spot for mutations associated with aminoglycoside ototoxicity These data have been providing valuable information and technology
to predict which individuals are at risk for ototoxicity, to improve the safety of aminoglycoside antibiotic therapy, and eventually to decrease the incidence of deafness
* Correspondence: min-xin.guan@cchmc.org
2 Attardi Institute of Mitochondrial Biomedicine and Zhejiang Provincial Key
Laboratory of Medical Genetics, School of Life Sciences, Wenzhou Medical
College, Wenzhou, Zhejiang, China
Full list of author information is available at the end of the article
© 2011 Shen et al; licensee BioMed Central Ltd This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
Trang 2Aminoglycosides, such as gentamicin and tobramycin,
are of great clinical importance for the treatment of
bac-terial infections The use of these drugs can frequently
lead to toxicity, which involves the renal, auditory and
vestibular systems [1,2] The renal impairment is usually
reversible, whereas the auditory and vestibular
city is usually irreversible In familial cases of
ototoxi-city, aminoglycoside hypersensitivity is often maternally
transmitted, suggesting that mutation(s) in
mitochon-drial DNA (mtDNA) is one of molecular bases for this
susceptibility [1,2] As mitochondrial ribosomes share
more similarities to bacterial ribosomes than do
cytoso-lic counterparts, the human mitochondrial 12 rRNA was
proposed to be the primary targeting site for
aminogly-cosides [3,4] The mutational analysis of mitochondrial
genome in several Chinese and Arab-Israeli families
with maternally transmitted aminoglycoside ototoxicity
or/and nonsyndromic deafness led to the landmark
dis-covery of the 12S rRNA 1555A > G mutation in 1993
[3] Subsequently, the 1555A > G mutation has been
found to be responsible for both
aminoglycoside-induced and nonsyndromic hearing loss in many
families worldwide [4-10] On the other hand, the 12S
rRNA 1494C > T mutation has been associated with
both aminoglycoside-induced and nonsyndromic hearing
loss only in some Chinese and Spanish families [11-13]
The 1555A > G and 1494C > T mutations are located
at the highly conserved A-site of 12S rRNA [4,11] The
A1555 and C1494 (equivalent to positions 1491 and 1409
of Escherichia coli 16S rRNA, respectively) are in
apposi-tion to each other but do not form a base-pair The
1555A > G or 1494C > T mutation creates a new G-C or
A-U pair base-pair, thereby extending the adjacent stem
by one nucleotide and making the secondary structure of
mitochondrial 12S rRNA more closely resemble the
cor-responding region of E coli 16S rRNA and altering
bind-ing properties of aminoglycosides such as paromomycin,
neomycin, gentamicin, and kanamycin at the A-site of
12S rRNA [14] Thus, the administration of
aminoglyco-sides can induce or worsen hearing loss in these subjects
carrying the 1555A > G or 1494C > T mutation In the
absence of aminoglycosides, matrilineal relatives within
and among families carrying the 1555A > G or 1494C >
T mutation exhibited a considerable phenotypic variation
with respect to severity and age-of-onset and penetrance
of hearing loss [4-13] Therefore, additional modifier
fac-tors such as aminoglycosides, nuclear and mitochondrial
genetic modifiers contributed to the phenotypic
variabil-ity of these mtDNA mutations [11,15-18]
However, the incidences of the 1555A > G and 1494C
> T mutations were only reported in the some cohorts
of hearing-impaired subjects [3,19-24] As these
mutations are only responsible for a portion of patients with hearing loss, it is anticipated that additional muta-tions causing hearing loss can be found in the same gene In the present investigation, we carried out a sys-tematic and extended mutational screening of 12S rRNA gene in a cohort of 440 hearing-impaired Han Chinese pediatric subjects from two otology clinics at Ningbo and Wenzhou, Zhejiang Province, China Muta-tional analysis of 12S rRNA gene in these subjects iden-tified the known 1555A > G and 1494C > T mutations
as well as 39 other variants Those variants have been further evaluated by phylogenetic analysis, structure-function relation and allelic frequency of these variants
in the 449 Han Chinese controls from the same region
To examine if the GJB2 gene contributed to a deafness phenotype, we performed the mutational screening of GJB2gene in 39 subjects carrying the known deafness-associated 12S rRNA mutations and 5 subjects carrying one of 5 putative 12S rRNA mutations
Methods
Subjects and audiological examinations
A total of 440 unrelated hearing-impaired Chinese sub-jects, who were younger than 18 years old two otology clinics from Zhejiang Province, were enrolled in this study under an institutional review board-approved pro-tocol of informed consent at the Cincinnati Children’s Hospital Medical Center Institutional Review Board and Ethics Committee of Wenzhou Medical College, China
A comprehensive history and physical examination for these participating subjects were performed to identify any syndromic findings, the history of the use of amino-glycosides, genetic factors related to the hearing impair-ment An age-appropriate audiological examination was performed and this examination included pure-tone audiometry (PTA) and/or auditory brainstem response (ABR), immittance testing and Distortion product otoa-coustic emissions (DPOAE) The PTA was calculated from the average of the audiometric thresholds at 500,
1000, 2000, 4000 and 8000 Hz The severity of hearing impairment was classified into five grades: normal <26 Decibel (dB); mild = 26-40 dB; moderate = 41-70 dB; severe = 71-90 dB; and profound >90 dB The 449 con-trol DNA used for screening for the presence of mtDNA variants were obtained from a panel of unaf-fected Han Chinese subjects from the same region
Mutational analysis of mitochondrial 12S rRNA gene
Genomic DNA was isolated from whole blood of parti-cipants using Puregene DNA Isolation Kits (Gentra Sys-tems, Minneapolis, Minnesota, USA) Subject’s DNA fragments spanning the 12S rRNA gene were amplified
by PCR using oligodeoxynucleotides corresponding to
Trang 3positions 618-635 and 1988-2007 [25] Each fragment
was purified and subsequently analyzed by direct
sequencing in an ABI 3700 automated DNA sequencer
using the Big Dye Terminator Cycle (Applied
Biosys-tems, Foster City, California, USA) sequencing reaction
kit The resultant sequence data were compared with
the updated consensus Cambridge sequence (GenBank
accession number: NC_012920) [26] The homoplasmy
of the 1555A > G and 1494C > T mutations in these
subjects were determined as detailed previously [7,11]
The frequency of variants in the 12S rRNA gene in 449
Chinese control subjects was determined by direct
sequencing of PCR products as described above
Mutational analysis ofGJB2 gene
The DNA fragments spanning the entire coding region
of GJB2 gene were amplified by PCR using the following
oligodeoxynucleotides:
forward-5’TATGACACTCCC-CAGCACAG3’ and
reverse-5’GGGCAATGCTTAAAC-TGGC3’ PCR amplification and subsequent sequencing
analysis were performed as detailed elsewhere [10] The
results were compared with the wild type GJB2
sequence (Version 1, GenBank accession number:
M86849) to identify the mutations
Structural analysis
The published secondary structures for the 12S rRNA
[27,28] were used to define the stem and loop structure
The secondary structure of human mitochondrial 12S
rRNA was predicted by using the RnaViz program [29]
Phylogenetic analysis
A total of 14 primate mitochondrial 12S rRNA
sequences (Genbank), as shown in Table 1, were used in
the interspecies analysis These include Homo sapiens, Gorilla gorilla, Pan paniscus, Pan troglodytes, Pongo pygmaeus, Pongo abelii, Hylobates lar, Macaca mulatta, Macaca sylvanus, Papio hamadryas, Cebus albifrons, Tarsius bancanus, Nycticebus coucang, and Lemur catta The conservation index (CI) was calculated by compar-ing the human nucleotide variants with other 13 pri-mates The CI was then defined as the percentage of species from the list of 14 different primates that have the wild-type nucleotide at that position
Results
Study samples
The study samples consisted of 227 males and 213 females The age of all participants ranged from 1 years old to 18 years, with the median age of 9 years All par-ticipants were Han Chinese recruited from ENT clinics
at Ningbo and Wenzhou Cities of Zhejiang Province, China Based on a clinician review of the medical record, 98 subjects (58 males and 40 females) had a his-tory of exposure to aminoglycosides including gentami-cin, streptomycin and kanamygentami-cin, accounting for 22.3% cases of hearing loss in this cohort These subjects, due
to infections or other illness, received a conventional daily dosage of aminoglycosides (3 5 mg/kg/dose every
8 h for gentamicin or 15 25 mg/kg/dose every 12 h for streptomycin, 15 mg/kg/dose every 8 h for kanamycin)
at younger than 10 years old Hearing impairment occurred from 3 days to three months after the adminis-tration of drugs Audiological evaluation showed that 22 subjects had severe hearing loss and 76 individuals exhibited profound hearing loss Furthermore, there was the wide range of severity of hearing loss in 342 affected subjects who did not have a history of exposure to ami-noglycosides: 149 subjects exhibited profound hearing loss, 167 subjects had severe hearing loss and 26 indivi-duals suffered from moderate hearing loss The onset of the hearing loss ranged from congenital to 10 years old
Mutational analysis of mitochondrial 12S rRNA gene
Fragments spanning 12S rRNA gene were PCR-amplified from genomic DNA of 440 hearing-impaired Chinese subjects and each fragment was purified and sub-sequently analyzed by DNA sequencing Comparison of the resultant sequence with the Cambridge consensus sequence [26] identified 41 nucleotide changes in the 12S rRNA gene as shown in Table 2 All the nucleotide changes were verified by sequence analysis of both strands and appeared to be homoplasmy Of these, 2 sub-jects with profound hearing loss carried the 1494C > T mutation Both subjects carrying the 1494C > T mutation had a history of exposure to aminoglycosides These translate to a frequency of ~0.45% for the 1494C > T mutation in this Chinese pediatric deafness population
Table 1 mtDNA sequence data of 14 primate species
Species name GenBank accession number
Homo sapiens NC_012920
Gorilla gorilla NC_001645
Pan paniscus NC_001644
Pan troglodytes NC_001643
Pongo pygmaeus NC_001646
Pongo abelii NC_002083
Hylobates lar NC_002082
Macaca mulatta NC_005943
Macaca sylvanus NC_002764
Papio hamadryas NC_001992
Cebus albifrons NC_002763
Tarsius bancanus NC_002811
Nycticebus coucang NC_002765
Lemur catta NC_004025
Trang 4Among these, 33 hearing-impaired subjects carrying
the 1555A > G mutation were composed of 21 subjects
who had a history of exposure to aminoglycosides and 12
individuals who did not receive aminoglycoside
treat-ment These translate to a frequency of ~7.5% for the
1555A > G mutation in this entire Chinese pediatric deafness population, and approximately 21.4% in cases of aminoglycoside ototoxicity in this Chinese pediatric population Furthermore, 4 subjects harbored the known deafness-associated 1095T > C mutation [30,31] and 11
Table 2 Variants in the mitochondrial 12S rRNA gene in 440 hearing-impaired Han Chinese subjects
Position Replacement Conservation
index (%)a
WC base-pairsb
Previously reportedc
Number of affected subjects
Percentage (%) Number of
controls (number/449)
Percentage (%)
a
The conservation index (CI) was then defined as the percentage of the human nucleotide variants with other 14 primates that have the wild-type nucleotide at that position.
b
Classic Watson-Crick (WC) base pair: created ( ↑) or abolished (↓).
c
See Ruiz-Pesini E, Wallace DC (2006) and http://www.mitomap.org; http://www.genpat.uu.se/mtDB.
d
Known and putative pathogenic variants are indicated in boldface.
Trang 5subjects carried the putative deafness-associated
muta-tions at position of 961 (961insC and 961T > C)
[7,21,32,33], respectively
In addition to the mutations mentioned above, there
were 34 known and 2 novel variants in the 12S rRNA
gene [34] These variants were first evaluated by
exam-ining the allelic frequency in 449 Han Chinese control
population Nineteen out of 41 variants were absent in
this Chinese control population Of other 22 variants,
the frequencies of 8 variants were <1% in 449 Chinese
controls, while the allelic frequency of other 14 variants
was >1% in this control population Furthermore, we
used the secondary structure of 12S rRNA [29,35] to
localize each variant with either a stem or a loop and to
analyze if the base changes within stems alter classic
Watson-Crick (WC) base pair [29,35] As shown in
Figure 1, 23 variants were located at the loops, while 18
variants occurred in the stems of this rRNA As shown
in Table 2 and Figure 1, 5 variants 1393G > A, 1413T >
C, 1494C > T, 1503G > A and 1555A > G created a
putative base-pairing(s), while 12 variants 663A > G,
681T > C, 709G > A, 747A > G, 839A > G, 929A > T,
951G > A, 980T > C, 990T > C, 1095T > C, 1310C > T
and 1382A > C abolished a putative base pairing(s)
This suggested that the nucleotide variants were more
frequent in loops than in stems In addition,
phyloge-netic analysis was performed by comparing the
human 12S rRNA nucleotide variants with other 13
primates As shown in Table 2, conservation index
(CI) among the variants ranged from 21.4% (1009C >
T variant) to 100% (752C > T and 747A > G variants)
In particular, CI of 18 variants including 1555A > G
and 1494C > T mutations were >78%, CI of other 13
variants was between 78% and 50% and CI for the
remaining variants was <50% In addition to the
1555A > G and 1494C > T mutations, the novel 747A
> G variant and the known 839A > G, 1027A > G,
1310C > T and 1413T > C variants [22,34], which are
absent in the 449 Chinese controls and whose CIs
were >78%, were the putative deafness-associated
var-iants On the other hand, other variants such as 663A
> G, 681T > C, 735A > G, 752C > T, 827A > G,
1107T > C and 1382A > C, whose CIs were >78%,
which were present in the controls, appeared to be
the polymorphisms
Clinical characterization of 39 hearing-impaired Chinese
subjects carrying one of known or 12S rRNA mutations
Comprehensive medical evaluations of 33 probands
car-rying the 1555A > G mutation, two subjects harboring
the 1494C > T mutation and four individuals carrying
the 1095T > C mutation showed no other clinical
abnormalities, including diabetes, muscular diseases,
visual loss and neurological disorders As shown in
Table 3, audiological assessments of 33 subjects carrying the 1555A > G mutation showed that 15, 3 and 3 sub-jects with the aminoglycoside treatments exhibited pro-found, severe or moderate hearing loss, respectively Moreover, 12 individuals, who did not have a history of exposure to aminoglycosides, exhibited a variety of severity and age-of-onset of hearing impairment The age-of-onset of hearing loss in these subjects ranged from infant to 18 years, with an average of 6 years Audiometric studies showed that 3 individuals suffered from profound hearing impairment, 5 subjects exhibited severe hearing impairment, 2 probands had moderate hearing impairment and 2 subjects exhibited mild hear-ing impairment Furthermore, two subjects carryhear-ing the 1494C > T mutation exhibited severe or profound hear-ing loss, respectively Among four subjects carryhear-ing the 1095T > C mutation, two subjects who was treated with aminoglycosides had profound and severe hearing loss, respectively, while two individuals who did not have a history to exposure exhibited profound and mild hearing impairment
Clinical and genetic characterization of 5 hearing-impaired Chinese subjects carrying one of 5 putative 12S rRNA mutation
Comprehensive medical histories of 5 probands carrying one of 5 putative 12S rRNA mutations and other mem-bers in these families showed no other clinical abnormal-ities, including diabetes, muscular diseases, visual loss and neurological disorders As shown in Table 3, two subjects received a regular dose of gentamicin for various illnesses at the age of 1 year, while other three subjects did not have a history of exposure to aminoglycosides There was no evidence that these subjects had any known cause to account for hearing loss Audiological examination indicated that 2 subjects suffered from severe hearing loss and 3 subjects exhibited profound hearing loss Variable patterns of audiometric configura-tions were detected in these subjects: 1 subject with slope-shaped pattern and 4 individuals with flat-shaped pattern Besides the proband, no one of the NS016 pedi-gree carrying the 747A > G variant suffered from hearing loss The pedigree FE239 with three matrilineal affected relatives carrying the 1027A > G mutation showed sug-gestively maternally transited hearing loss Furthermore, two matrilineal relatives of 14 members in the pedigree NB005 carrying the 839A > G mutation, as shown in Figure 2, suffered from hearing loss In addition, four of
16 members in the pedigree ZX039 carrying the 1413T >
C variant experienced the loss of hearing
Mutational analysis ofGJB2 gene
To examine if the GJB2 gene contributed to a deafness phenotype, we performed the mutational screening of
Trang 6GJB2gene in 39 subjects carrying the known
deafness-associated 12S rRNA mutations and 5 subjects carrying
one of 5 putative 12S rRNA mutations As shown in
Table 3, the subject ZX039-IV-1 carrying the 12S
rRNA 1413T > C mutation harbored the known
235DelC/299DelAT mutation in the GJB2 gene [36,37],
while none of other mutations in GJB2 gene was detected in other 43 affected subjects Indeed, the absence of mutation in the GJB2 gene in those subjects with hearing impairment indicated that the GJB2 gene did not contribute to the deafness phenotype in those subjects
Figure 1 Structure and sequence variants of human mitochondrial 12S rRNA The secondary structure was predicted by using the RnaViz program (De Rijk and De Wachter, 1997) The variants were indicated by arrows.
Trang 7Table 3 Summary of clinical and molecular data for 44 Han Chinese subjects carrying the putative 12S rRNA
mutations
12S rRNA
mutation GJB2 gene
mutation
Subjects Gender Audiometic
configuration
Age-at-onset (years)
PTAa (dB) right ear
PTA (dB) left ear
Use of drugs
Level of hearing impairment
1555A > G polymorphism
FE0128-IV-1
1555A > G polymorphism
FE020-III-15
1555A > G polymorphism FE300-II-12 F Slope 3 110 105 Yes Profound
1555A > G polymorphism
FE317-III-10
1555A > G polymorphism
ZX025-III-14
1413T > C 235DelC/
299DelAT
a
Trang 8The cohort of Chinese pediatric hearing-impaired
sub-jects consisted of 98 subsub-jects with aminoglycoside
oto-toxicity and 342 subjects, who did not have a history of
exposure to aminoglycosides Of known
deafness-associated 12S rRNA mutations, the 1555A > G
muta-tion accounted for 7.5% cases of this Chinese clinical
population, while incidences of this mutation were
1.76% and 3.96% in two large cohorts of hearing
impaired pediatric Han Chinese subjects from schools of
deaf children [22,36] In the present study, the
inci-dences of the 1555A > G mutation were 2.7% and 21.4%
cases of nonsyndromic and aminoglycoside-induced
hearing loss, respectively In fact, the incidences of the
1555A > G mutation varied among different ethnic
ori-gins With regard to the subjects with aminoglycoside
ototoxicity, the incidences of the 1555A > G mutation
were 33% in a small Japanese cohort [19] 13%, 10.4%
and 5% in three Chinese cohorts [3,21,22] and ~17% in
the two white cohorts from United States and Spain
[5,32,33] However, the incidence of 1555A > G
muta-tion in nonsyndromic hearing loss was much lower than
in those with aminoglycoside ototoxicity In two white
cohorts with nonsyndromic hearing loss, the frequency
of the 1555A > G mutation varied from 0.6% to 2.5%
[20,24], while the incidence of the 1555A > G mutation
in several Asian cohorts ranged from 2.9% to 5.3%
[19,21-23] Thus, the large proportion of subjects with
aminoglycoside ototoxicity in this cohort may contribute
to higher incidence of the 1555A > G mutation than other cohorts On the other hand, the incidences of the 1494C > T mutation appeared to be lower than those of the 1555A > G mutation In this cohort, two subjects carrying the 1494C > T mutation had a history of expo-sure to aminoglycosides This data appeared to be higher than the previous reports that three familial cases
of 1340 sporadic Spanish hearing-impaired subjects car-ried the 1494C > T mutation [12] and three cases of
1642 pediatric deaf children [22] Therefore, these two known 12S rRNA mutations account for from 4% to 8% cases among these Chinese hearing-impaired popula-tions [10]
Of other known deafness-mutations, the frequency of the 1095T > C mutation was 0.91% in this cohort The 1095T > C mutation, whose CI was 92.9%, occurred in one of 449 Chinese controls This mutation has been found in several genetically-unrelated families with non-syndromic and aminoglycoside-induced hearing loss [21,22,30,31] This T-to-C transition disrupted an evolu-tionarily conserved base-pair at stem loop of the helix
25 of 12S rRNA [27] This nucleotide is also located at the P-site of ribosome, suggesting an important role in the initiation of mitochondrial protein synthesis [31] Furthermore, the frequency of mutations at position 961 including 961insC and 961T > C was 2.27% in this pediatric population Although mutations at this
NS016 with 747A>G variant NB005 with 839A>G variant
FE239 with 1027A>G variant NS017 with 1310C>T variant ZX039 with 1413T>C variant
*
Figure 2 Five Han Chinese pedigrees with aminoglycoside-induced and nonsyndromic hearing impairment Hearing impaired individuals are indicated by filled symbols Arrowhead denotes probands Asterisks denote individuals who had a history of exposure to aminoglycosides.
Trang 9position have been implicated to be associated with
hearing loss in different ethnic groups [21,22,32,33], the
lower CI (42.9%) and presence of 4% in the controls
indicated that mutations in this position were
polymorphisms
A total of 41 (39 known and 2 novel) variants in 12S
rRNA gene were identified in this cohort Similar to
other mtDNA variations, these variants can be grouped
into three categories: neutral, adaptive and deleterious
[35] To identify putative deleterious mutation, these
variants were further evaluated using following three
cri-teria: 1) Absent in the 449 Chinese controls; 2) CI is
>78%, proposed by Ruiz-Pesini and Wallace [35];
3) Potential structural and functional alterations [22]
Among these variants, 19 variant were absent in the 449
Han Chinese controls, while the frequency of other
var-iants ranged from 0.2% (13 varvar-iants such as 789T > C)
to 22.7% (709G > A variant) in this Chinese control
population In particular, some of these variants
occur-ring at high frequencies of both control and patient
populations were the mitochondrial haplogroup specific
variants [36] These included the 663A > G variant of
haplogroup A, the 827A > G and 1119T > C variants of
haplogroup B4, the 709G > A and 1598G > A variants
of haplogroup B5, the 1382A > C variant of haplogroup
D4, the 681T > C, 752C > T, 1048C > T and 1107T > C
variants of D5 haplogroup, the haplogroup F2 specific
variant 1005T > C, the 1041A > G variant of haplogroup
M9a, and the 1541T > C variant of haplogroup R5b
[38] Apparently, these haplogroup specific variants were
adaptive or neutral but unlikely deleterious
Phylogenetic analysis showed that CIs of 28 variants
were more than 78% Despite their higher CI, the 14
variants such as 663A > G, 681T > C, 752C > T, 735A
> G, 827A > G, 1107T > C, 1382A > C and 1438A >
G were present in the controls On the other hand, the
CIs for other 7 variants including 1555A > G and
1494C > T were at least 78% but these variants were
absent in 449 Chinese controls Based on the predicted
secondary structure of mitochondrial 12S rRNA
[27,35], 23 variants were located at the loops and 18
variants occurred in the stems of this rRNA Among
these variants, 11 variants including the 1095T > C
disrupted a WC base pairing(s) of 12S rRNA, while 5
variants including the 1555A > G and 1494C > T
cre-ated a novel WC base-pairing(s) of this rRNA [28,29]
In fact, the 1555A > G or 1494C > T mutation made
the mitochondrial ribosome more bacteria-like
[4,11,14] Functional characterization demonstrated
that the 1555A > G or 1494C > T mutation conferred
sensitivity to aminoglycosides [11,15,16,18] Thus,
indi-viduals carrying either of mutations are predisposed to
hearing loss Indeed, the novel 747A > G variant and
the known 839A > G, 1310C > T and 1413T > C
variants [22,34], which resided at the stems of 12S rRNA, were fitted with three criteria for the patho-genic mutations as described above Furthermore, the 1027A > G variant, whose location was at a loop in the 12S rRNA and whose CI was 92.9%, was absent in
449 Han Chinese controls Thus, alterations of the ter-tiary or quaternary structure of 12S rRNA by these putative variants may lead to significant effects on function, thereby contributing to the deafness pheno-type Genetic and clinical evaluations of these five hearing-impaired Chinese subjects carrying one of 5 putative 12S rRNA mutation were performed The pedigree FE239 carrying the 1027A > G mutation exhib-ited suggestively maternally transexhib-ited hearing loss, while other four pedigrees did not have a typically maternal inheritance of hearing loss The presence of the known 235DelC/299DelAT mutation in the GJB2 gene in the subject ZX039-IV-1 carrying the 1413T > C mutation indicated its role in the deafness phenotype The absence of mutation(s) in the GJB2 gene in other four subjects suggested the involvement of other modifier factors in the phenotypic manifestation of these putative deafness-associated 12S rRNA variants, as in the case of these families carrying the 1555A > G mutation [39] Further genetic and biochemical characterizations were necessary for the understanding the pathophysiology of these putative deafness-associated 12S rRNA mutations Moreover, approximately 70% of subjects with amino-glycoside-indece hearing loss in this cohort did not carry the pathogenic 12S rRNA 1555A > G and 1494C >
T mutations as well as putative deafness-associated 12S rRNA mutations These data implicated the involve-ment of other nuclear genes, besides mitochondrial 12S rRNA mutations, in development of hearing loss in these subjects
Conclusions
Mutations in mitochondrial 12S rRNA gene accounted for approximately 30% cases of aminoglycoside-induced hearing loss in this cohort These results strongly sup-port the idea that the mitochondrial 12S rRNA is the hot spot for mutations associated with aminoglycoside ototoxicity These data have been providing valuable information and technology to predict which individuals are at risk for ototoxicity, to improve the safety of ami-noglycoside antibiotic therapy, and eventually to decrease the incidence of deafness
Acknowledgements This work was supported by Public Health Service grants RO1DC05230 and RO1DC07696 from the National Institute on Deafness and Other
Communication Disorders, and grants from National Basic Research Priorities Program of China 2004CCA02200, Ministry of Public Heath of Zhejiang Province 2006A100, Ministry of Science and Technology of Zhejiang Province 2007G50G2090026 and Zhejiang Provincial Program for
Trang 10the Cultivation of High-level Innovative Health talents to M.X.G and
Ministry of Science and Natural Science Foundation of Zhejiang Province
Y207307 to Y.Z.
Author details
1 Department of Otolaryngology, Ningbo Medical Center, Li Huili Hospital,
Ningbo, Zhejiang, China.2Attardi Institute of Mitochondrial Biomedicine and
Zhejiang Provincial Key Laboratory of Medical Genetics, School of Life
Sciences, Wenzhou Medical College, Wenzhou, Zhejiang, China.3Department
of Otolaryngology, the Second Affiliated Hospital, Wenzhou Medical College,
Wenzhou, Zhejiang, China 4 Department of Otolaryngology, Yuyao People ’s
Hospital, Yuyao, Zhejiang, China 5 Department of Otolaryngology, the First
Affiliated Hospital, Wenzhou Medical College, Wenzhou, Zhejiang, China.
6
Department of Human Genetics, Cincinnati Children ’s Hospital Medical
Center, Cincinnati, Ohio 45229, USA 7 Deparment of Pediatrics, University of
Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Authors ’ contributions
The work presented here was carried out in collaboration between all
authors ZS, BC, GP, YZ, CZ, JZ, TC LJ participated in the clinical data
collection JZ, TZ, SG, RL, LY performed the mitochondrial 12S rRNA
sequence analysis and data collection JL participated in the design of the
study MXG conceived of the study, participated in its design and
coordination and drafted the manuscript All authors read and approved the
final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 23 August 2010 Accepted: 4 January 2011
Published: 4 January 2011
References
1 Fischel-Ghodsian N: Genetic factors in aminoglycoside toxicity.
Pharmacogenomics 2005, 6:27-36.
2 Guan MX: Prevalence of mitochondrial 12S rRNA mutations associated
with aminoglycoside ototoxicity Volta Review 2005, 105:211-237.
3 Hutchin T, Haworth I, Higashi K, Fischel-Ghodsian N, Stoneking M, Saha N,
Arnos C, Cortopassi G: A molecular basis for human hypersensitivity to
aminoglycoside antibiotics Nuclear Acids Res 1993, 21:4174-4179.
4 Prezant TR, Agapian JV, Bohlman MC, Bu X, Oztas S, Qiu WQ, Arnos KS,
Cortopassi GA, Jaber L, Rotter JI, Shohat M, Fischel-Ghodsian N:
Mitochondrial ribosomal RNA mutation associated with both
antibiotic-induced and non-syndromic deafness Nature Genet 1993, 4:289-294.
5 Estivill X, Govea N, Barcelo E, Badenas C, Romero E, Moral L, Scozzari R,
D ’Urbano L, Zeviani M, Torroni A: Familial progressive sensorineural
deafness is mainly due to the mtDNA A1555G mutation and is
enhanced by treatment with aminoglycosides Am J Hum Genet 1998,
62:27-35.
6 Matthijs G, Claes S, Longo-Bbenza B, Cassiman J-J: Non-syndromic
deafness associated with a mutation and a polymorphism in the
mitochondrial 12S ribosomal RNA gene in a large Zairean pedigree Eur
J Hum Genet 1996, 4:46-51.
7 Li R, Xing G, Yan M, Cao X, Liu XZ, Bu X, Guan MX: Cosegregation of
C-insertion at position 961 with A1555G mutation of mitochondrial 12S
rRNA gene in a large Chinese family with maternally inherited hearing
loss Am J Med Genet 2004, 124A:113-117.
8 Tang X, Yang L, Zhu Y, Liao Z, Wang J, Qian Y, Tao Z, Hu L, Wu G, Lan J,
Wang X, Ji J, Wu J, Ji Y, Feng J, Chen J, Li Z, Zhang X, Lu J, Guan MX: Very
low penetrance of hearing loss in seven Han Chinese pedigrees carrying
the deafness-associated 12S rRNA A1555G mutation Gene 2007,
393:11-19.
9 Chen B, Sun D, Yang L, Zhang C, Yang A, Zhu Y, Zhao J, Chen Y, Guan M,
Wang X, Li R, Tang X, Wang J, Tao Z, Lu J, Guan MX: Mitochondrial ND5
T12338C, tRNA Cys T5802C, and tRNA Thr G15927A variants may have a
modifying role in the phenotypic manifestation of deafness-associated
12S rRNA A1555G mutation in three Han Chinese pedigrees Am J Med
Genet 2008, 146A:1248-1258.
10 Lu J, Qian Y, Li Z, Yang A, Zhu Y, Li R, Yang L, Tang X, Chen B, Ding Y, Li Y,
You J, Zheng J, Tao Z, Zhao F, Wang J, Sun D, Zhao J, Meng Y, Guan MX:
of the deafness-associated 12S rRNA 1555A > G mutation Mitochondrion
2010, 10:69-81.
11 Zhao H, Li R, Wang Q, Yan Q, Deng JH, Han D, Bai Y, Young WY, Guan MX: Maternally inherited aminoglycoside-induced and nonsyndromic deafness is associated with the novel C1494T mutation in the mitochondrial 12S rRNA gene in a large Chinese family Am J Hum Genet
2004, 74:139-152.
12 Rodriguez-Ballesteros M, Olarte M, Aguirre LA, Galan F, Galan R, Vallejo LA, Navas C, Villamar M, Moreno-Pelayo MA, Moreno F, del Castillo I: Molecular and clinical characterisation of three Spanish families with maternally inherited non-syndromic hearing loss caused by the 1494C- > T mutation in the mitochondrial 12S rRNA gene J Med Genet 2006, 43:e54.
13 Chen J, Yang L, Yang A, Zhu Y, Zhao J, Sun D, Tao Z, Tang X, Wang J, Wang X, Tsushima A, Lan J, Li W, Wu F, Yuan Q, Ji J, Feng J, Wu C, Liao Z,
Li Z, Greinwald JH, Lu J, Guan MX: Maternally inherited aminoglycoside-induced and nonsyndromic hearing loss is associated with the 12S rRNA C1494T mutation in three Han Chinese pedigrees Gene 2007, 401:4-11.
14 Qian Y, Guan MX: Interaction of aminoglycosides with human mitochondrial 12S ribosomal RNA carrying the deafness-associated mutation Antimicrob Agents Chemother 2009, 53:4612-4618.
15 Guan MX, Fischel-Ghodsian N, Attardi G: Biochemical evidence for nuclear gene involvement in phenotype of nonsyndromic deafness associated with mitochondrial 12S rRNA mutation Hum Mol Genet 1996, 5:963-971.
16 Guan MX, Fischel-Ghodsian N, Attardi G: A biochemical basis for the inherited susceptibility to aminoglycoside ototoxicity Hum Mol Genet
2000, 9:1787-1793.
17 Guan MX, Yan Q, Li X, Bykhovskaya Y, Gallo-Teran J, Hajek P, Umeda N, Zhao H, Garrido G, Mengesha E, Suzuki T, del Castillo I, Peters JL, Li R, Qian Y, Wang X, Ballana E, Shohat M, Lu J, Estivill X, Watanabe K, Fischel-Ghodsian N: Mutation in TRMU related to transfer RNA modification modulates the phenotypic expression of the deafness-associated mitochondrial 12S ribosomal RNA mutations Am J Hum Genet 2006, 79:291-302.
18 Zhao H, Young WY, Yan Q, Li R, Cao J, Wang Q, Li X, Peters JL, Han D, Guan MX: Functional characterization of the mitochondrial 12S rRNA C1494T mutation associated with aminoglycoside-induced and nonsyndromic hearing loss Nucleic Acid Res 2005, 33:1132-1139.
19 Usami S, Abe S, Akita J, Namba A, Shinkawa H, Ishii M, Iwasaki S, Hoshino T, Ito J, Doi K, Kubo T, Nakagawa T, Komiyama S, Tono T, Komune S: Prevalence of mitochondrial gene mutations among hearing impaired patients J Med Genet 2000, 37:38-40.
20 Li R, Greinwald JH, Yang L, Choo DI, Wenstrup RJ, Guan MX: Molecular analysis of mitochondrial 12S rRNA and tRNA Ser(UCN) genes in paediatric subjects with nonsyndromic hearing loss J Med Genet 2004, 41:615-620.
21 Li Z, Li R, Chen J, Liao Z, Zhu Y, Qian Y, Xiong S, Heman-Ackah S, Wu J, Choo DI, Guan MX: Mutational analysis of the mitochondrial 12S rRNA gene in Chinese pediatric subjects with aminoglycoside induced and non-syndromic hearing loss Hum Genet 2005, 117:9-15.
22 Lu J, Li Z, Zhu Y, Yang A, Li R, Zheng J, Cai Q, Peng G, Zheng W, Tang X, Chen B, Chen J, Liao Z, Yang L, Li Y, You J, Ding Y, Yu H, Wang J, Sun D, Zhao J, Xue L, Wang J, Guan MX: Mitochondrial 12S rRNA variants in
1642 Han Chinese pediatric subjects with aminoglycoside-induced and nonsyndromic hearing loss Mitochondrion 2010, 10:380-390.
23 Malik SG, Pieter N, Sudoyo H, Kadir A, Marzuki S: Prevalence of the mitochondrial DNA A1555G mutation in sensorineural deafness patients
in island Southeast Asia J Hum Genet 2003, 48:480-483.
24 Jacobs HT, Hutchin TP, Käppi T, Gillies G, Minkkinen K, Walker J, Thompson K, Rovio AT, Carella M, Melchionda S, Zelante L, Gasparini P, Pyykkö I, Shah ZH, Zeviani M, Mueller RF: Mitochondrial DNA mutations in patients with postlingual, nonsyndromic hearing impairment Eur J Hum Genet 2005, 13:26-33.
25 Rieder MJ, Taylor SL, Tobe VO, Nickerson DA: Automating the identification of DNA variations using quality-based fluorescence re-sequencing: analysis of the human mitochondrial genome Nucleic Acids Res 1998, 26:967-973.
26 Andrews RM, Kubacka I, Chinnery PF, Lightowlers RN, Turnbull DM, Howell N: Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA Nat Genet 1999, 23:147.
27 Neefs JM, Van de Peer Y, De Rijik P, Goris A, De Wachter R: Compilation of small ribosomal subunit RNA sequences Nucleic Acids Res 1991, 19(Suppl):1987-2018.